B4GALNT4 and cancer: Additionally, GSEA analysis revealed that multiple cancer-related pathways were inhibited after the knockdown of B4GALNT4, including the PI3K−Akt signaling pathway, Rap1 signaling pathway, and Wnt signaling pathway.